Do you want to read an article? Please log in or register.
Clinical utility of fractional exhaled nitric oxide (FeNO) in severe asthma management
Asthma
COMMENTED
Related content
RECOMMENDED
Asthma
"T2-high" in severe asthma related to blood eosinophil, exhaled nitric oxide and serum periostin
Eur Respir J.
Pavlidis S, Takahashi K, Ng Kee Kwong F, Xie J, Hoda U, Sun K, Elyasigomari V, Agapow P, Loza M, Baribaud F, Chanez P, Fowler SJ, Shaw DE, Fleming LJ, Howarth PH, Sousa AR, Corfield J, Auffray C, De Meulder B, Knowles R, Sterk PJ, Guo Y, Adcock IM, Djukanovic R, Fan Chung K, on behalf of the U-BIOPRED Study Group
doi: 10.1183/13993003.
Clinical features in patients of cough variant asthma with normal and high level of exhaled fractional nitric oxide
Clin Respir J.
Tang W, Zhou J, Miao L, Shi G
doi: 10.1111/crj.12568.
Fractional exhaled nitric oxide as a predictor of response to inhaled corticosteroids in patients with non-specific respiratory symptoms and insignificant bronchodilator reversibility: a randomised controlled trial
Lancet Respir Med.
Price DB, Buhl R, Chan A, Freeman D, Gardener E, Godley C, Gruffydd-Jones K, McGarvey L, Ohta K, Ryan D, Syk J, Tan NC, Tan T, Thomas M, Yang S, Konduru PR, Ngantcha M, d'Alcontres MS, Lapperre TS
doi: 10.1016/
Managing Asthma in Pregnancy (MAP) trial: FeNO levels and childhood asthma
J Allergy Clin Immunol.
Morten M, Collison A, Murphy VE, Barker D, Oldmeadow C, Attia J, Meredith J, Powell H, Robinson PD, Sly PD, Gibson PG, Mattes J
doi: 10.1016/j.jaci.2018.02.039.
RECOMMENDED
Asthma
Disconnect of type 2 biomarkers in severe asthma; dominated by FeNO as a predictor of exacerbations and periostin as predictor of reduced lung function
Respir Med.
Mansur AH, Srivastava S, Sahal A
doi: 10.1016/j.rmed.2018.08.005.
RECOMMENDED
Asthma
Use of Fractional Exhaled Nitric Oxide to Guide the Treatment of Asthma: An Official American Thoracic Society Clinical Practice Guideline
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 3
Recommended by
Dr Marcus Hesse, Faculty Member
Am J Respir Crit Care Med
Khatri SB, Iaccarino JM, Barochia A, Soghier I, Akuthota P, Brady A, Covar RA, Debley JS, Diamant Z, Fitzpatrick AM, Kaminsky DA, Kenyon NJ, Khurana S, Lipworth BJ, McCarthy K, Peters M, Que LG, Ross KR, Schneider-Futschik EK, Sorkness CA, Hallstrand TS, American Thoracic Society Assembly on Allergy, Immunology, and Inflammation.
doi: 10.1164/rccm.202109-2093ST
Combined use of fractional exhaled nitric oxide and bronchodilator response in predicting future loss of asthma control among children with atopic asthma
Respirology.
Kim JK, Jung JY, Kim H, Eom SY, Hahn YS
doi: 10.1111/resp.12934.
Diagnosis and Management of Severe Asthma
Semin Respir Crit Care Med.
Chung KF
doi: 10.1055/s-0037-1607391.
COMMENTED
Asthma
Using fractional exhaled nitric oxide to guide step down treatment decisions in patients with asthma: a systematic review and individual patient data meta-analysis
★ 3
Recommended and commented by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
doi: 10.1183/13993003.02150-2019.